Abstract
Pregnancy may transiently alter clinical features of benign melanocytic nevi (BMN) but does not increase the rate of malignant transformation. Changes in size and/or pigment network are minor, infrequent, and typically associated with anatomic sites prone to skin stretching in pregnancy. Females with dysplastic nevus syndrome (DNS) may have elevated risk of malignant transformation and should be monitored closely during pregnancy. Approximately 8% of malignant melanoma (MM) cases occur during pregnancy; therefore, screening, evaluation, and biopsy of suspicious lesions are paramount to avoid delayed diagnosis of MM during pregnancy. It is unclear whether pregnancy worsens outcome or survival for MM; translational and clinical studies show complex and conflicting trends. Two recent meta-analyses report a 17–56% elevated risk of mortality for pregnancy-associated malignant melanoma (PAMM); however, controversy still exists among experts as data is limited and analysis methods have been criticized. Early-stage PAMM does not cause poor fetal or maternal pregnancy outcomes, but metastatic MM is the most common cancer to spread to the placenta and fetus. PAMM should be treated according to standard guidelines for MM whenever possible, with expeditious surgery the main treatment modality for localized MM. The safety of systemic targeted and immunotherapy for MM in pregnancy is unknown; expert multidisciplinary teams should manage advanced-stage PAMM. Pregnancy following diagnosis and treatment of MM does not have any fetal or maternal adverse effects, but counseling should be individualized based on stage of disease and maternal preferences in cases with high risk for recurrence or metastasis.
Keywords
Malignant melanoma Pregnancy Pregnancy-associated melanoma Melanocytic nevi Management Prognosis ReviewReferences
- 1.Walker JL, Wang AR, Kroumpouzos G, Weinstock MA. Cutaneous tumors in pregnancy. Clin Dermatol. 2016;34(3):359–67.CrossRefPubMedGoogle Scholar
- 2.Nading MA, Nanney LB, Boyd AS, Ellis DL. Estrogen receptor beta expression in nevi during pregnancy. Exp Dermatol. 2008;17(6):489–97.CrossRefPubMedPubMedCentralGoogle Scholar
- 3.Ellis DL. Pregnancy and sex steroid hormone effects on nevi of patients with the dysplastic nevus syndrome. J Am Acad Dermatol. 1991;25(3):467–82.CrossRefPubMedGoogle Scholar
- 4.Foucar E, Bentley TJ, Laube DW, Rosai J. A histopathologic evaluation of nevocellular nevi in pregnancy. Arch Dermatol. 1985;121(3):350–4.CrossRefPubMedGoogle Scholar
- 5.Chan MP, Chan MM, Tahan SR. Melanocytic nevi in pregnancy: histologic features and Ki-67 proliferation index. J Cutan Pathol. 2010;37(8):843–51.CrossRefPubMedGoogle Scholar
- 6.Wyon Y, Synnerstad I, Fredrikson M, Rosdahl I. Spectrophotometric analysis of melanocytic naevi during pregnancy. Acta Derm Venereol. 2007;87(3):231–7.PubMedGoogle Scholar
- 7.Akturk AS, Bilen N, Bayramgurler D, Demirsoy EO, Erdogan S, Kiran R. Dermoscopy is a suitable method for the observation of the pregnancy-related changes in melanocytic nevi. J Eur Acad Dermatol Venereol. 2007;21(8):1086–90.CrossRefPubMedGoogle Scholar
- 8.Rubegni P, Sbano P, Burroni M, Cevenini G, Bocchi C, Severi FM, et al. Melanocytic skin lesions and pregnancy: digital dermoscopy analysis. Skin Res Technol. 2007;13(2):143–7.CrossRefPubMedGoogle Scholar
- 9.Zampino MR, Corazza M, Costantino D, Mollica G, Virgili A. Are melanocytic nevi influenced by pregnancy? A dermoscopic evaluation. Dermatol Surg. 2006;32(12):1497–504.PubMedGoogle Scholar
- 10.Sanchez JL, Figueroa LD, Rodriguez E. Behavior of melanocytic nevi during pregnancy. Am J Dermatopathol. 1984;6(Suppl):89–91.PubMedGoogle Scholar
- 11.Strumia R. Digital epiluminescence microscopy in nevi during pregnancy. Dermatology. 2002;205(2):186–7.CrossRefPubMedGoogle Scholar
- 12.Gunduz K, Koltan S, Sahin MT, EF E. Analysis of melanocytic naevi by dermoscopy during pregnancy. J Eur Acad Dermatol Venereol. 2003;17(3):349–51.CrossRefPubMedGoogle Scholar
- 13.Pennoyer JW, Grin CM, Driscoll MS, Dry SM, Walsh SJ, Gelineau JP, et al. Changes in size of melanocytic nevi during pregnancy. J Am Acad Dermatol. 1997;36(3 Pt 1):378–82.CrossRefPubMedGoogle Scholar
- 14.Tierney EKG, Tumors RGS. In: Kroumpouzos G, editor. Text atlas of obstretric dermatology. Philadelphia: Lippincott Williams & Wilkins Publishers; 2013. p. 141–51.Google Scholar
- 15.Andersson TM, Johansson AL, Fredriksson I, Lambe M. Cancer during pregnancy and the postpartum period: a population-based study. Cancer. 2015;121(12):2072–7.CrossRefPubMedGoogle Scholar
- 16.Stensheim H, Moller B, van Dijk T, Fossa SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol. 2009;27(1):45–51.CrossRefPubMedGoogle Scholar
- 17.Lee YY, Roberts CL, Dobbins T, Stavrou E, Black K, Morris J, et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994–2008: a population-based linkage study. BJOG. 2012;119(13):1572–82.CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Eibye S, Kjaer SK, Mellemkjaer L. Incidence of pregnancy-associated cancer in Denmark, 1977–2006. Obstet Gynecol. 2013;122(3):608–17.CrossRefPubMedGoogle Scholar
- 19.Lens M, Rosdahl I, Newton-Bishop J. Cutaneous melanoma during pregnancy: is the controversy over? J Clin Oncol. 2009;27(19):e11–2; author reply e3–4CrossRefPubMedGoogle Scholar
- 20.Jones MS, Lee J, Stern SL, Faries MBI. Pregnancy-associated melanoma associated with adverse outcomes? J Am Coll Surg. 2017;225(1):149–58.CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Peccatori FA, Azim HA Jr, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi160–70.CrossRefPubMedGoogle Scholar
- 22.Purdue MP, Freeman LE, Anderson WF, Tucker MA. Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol. 2008;128(12):2905–8.CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Bleyer WA. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol. 2002;38(1):1–10.CrossRefPubMedGoogle Scholar
- 24.Bannister-Tyrrell M, Roberts CL, Hasovits C, Nippita T, Ford JB. Incidence and outcomes of pregnancy-associated melanoma in New South Wales 1994–2008. Aust N Z J Obstet Gynaecol. 2015;55(2):116–22.CrossRefPubMedGoogle Scholar
- 25.Khosrotehrani K, Nguyen Huu S, Prignon A, Avril MF, Boitier F, Oster M, et al. Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis. Am J Pathol. 2011;178(4):1870–80.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Cristiani CM, Palella E, Sottile R, Tallerico R, Garofalo C, Carbone E. Human NK cell subsets in pregnancy and disease: Toward a new biological complexity. Front Immunol. 2016;7:656.CrossRefPubMedPubMedCentralGoogle Scholar
- 27.Johansen LL, Lock-Andersen J, Hviid TV. The pathophysiological impact of HLA class Ia and HLA-G expression and regulatory T cells in malignant melanoma: a review. J Immunol Res. 2016;2016:6829283.CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Baumgartner JM, Gonzalez R, Lewis KD, Robinson WA, Richter DA, Palmer BE, et al. Increased survival from stage IV melanoma associated with fewer regulatory T cells. J Surg Res. 2009;154(1):13–20.CrossRefPubMedGoogle Scholar
- 29.Fabian M, Toth V, Somlai B, Harsing J, Kuroli E, Rencz F, et al. Retrospective analysis of clinicopathological characteristics of pregnancy associated melanoma. Pathol Oncol Res. 2015;21(4):1265–71.CrossRefPubMedGoogle Scholar
- 30.Vihinen P, Vainio-Kaila M, Talve L, Koskivuo I, Syrjanen K, Pyrhonen S. Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma. Acta Oncol. 2012;51(5):662–8.CrossRefPubMedGoogle Scholar
- 31.Roh MR, Eliades P, Gupta S, Tsao H. Cutaneous melanoma in women. Int J Womens Dermatol. 2015;1(1):21–5.CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Kaae J, Andersen A, Boyd HA, Wohlfahrt J, Melbye M. Reproductive history and cutaneous malignant melanoma: a comparison between women and men. Am J Epidemiol. 2007;165(11):1265–70.CrossRefPubMedGoogle Scholar
- 33.Zhou JH, Kim KB, Myers JN, Fox PS, Ning J, Bassett RL, et al. Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men. Am J Dermatopathol. 2014;36(1):74–9.CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Fabian M, Rencz F, Krenacs T, Brodszky V, Harsing J, Nemeth K, et al. Expression of G protein-coupled estrogen receptor, GPER in melanoma and in pregnancy-associated melanoma. J Eur Acad Dermatol Venereol. 2017;31(9):1453–61.CrossRefPubMedGoogle Scholar
- 35.Beguerie JR, Xingzhong J, Valdez RP. Tamoxifen vs. non-tamoxifen treatment for advanced melanoma: a meta-analysis. Int J Dermatol. 2010;49(10):1194–202.CrossRefPubMedGoogle Scholar
- 36.Lens MB, Reiman T, Husain AF. Use of tamoxifen in the treatment of malignant melanoma. Cancer. 2003;98(7):1355–61.CrossRefPubMedGoogle Scholar
- 37.Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer. 2004;11(3):537–51.CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Merkel EA, Martini MC, Amin SM, Yelamos O, Lee CY, Sholl LM, et al. A comparative study of proliferative activity and tumor stage of pregnancy-associated melanoma (PAM) and non-PAM in gestational age women. J Am Acad Dermatol. 2016;74(1):88–93.CrossRefPubMedGoogle Scholar
- 39.Prithviraj P, Anaka M, McKeown SJ, Permezel M, Walkiewicz M, Cebon J, et al. Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion. Oncotarget. 2015;6(18):15953–65.CrossRefPubMedPubMedCentralGoogle Scholar
- 40.Rodero MP, Prignon A, Avril MF, Boitier F, Aractingi S, Khosrotehrani K. Increase lymphangiogenesis in melanoma during pregnancy: correlation with the prolactin signalling pathway. J Eur Acad Dermatol Venereol. 2013;27(1):e144–5.CrossRefPubMedGoogle Scholar
- 41.Dadras SS, Lange-Asschenfeldt B, Velasco P, Nguyen L, Vora A, Muzikansky A, et al. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol. 2005;18(9):1232–42.CrossRefGoogle Scholar
- 42.Massi D, Puig S, Franchi A, Malvehy J, Vidal-Sicart S, Gonzalez-Cao M, et al. Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study. J Clin Pathol. 2006;59(2):166–73.CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Cirello V, Fugazzola L. Novel insights into the link between fetal cell microchimerism and maternal cancers. J Cancer Res Clin Oncol. 2016;142(8):1697–704.CrossRefPubMedGoogle Scholar
- 44.Nguyen Huu S, Oster M, Avril MF, Boitier F, Mortier L, Richard MA, et al. Fetal microchimeric cells participate in tumour angiogenesis in melanomas occurring during pregnancy. Am J Pathol. 2009;174(2):630–7.CrossRefPubMedPubMedCentralGoogle Scholar
- 45.Conybeare RC. Malignant melanoma and pregnancy: report of 3 cases. Obstet Gynecol. 1964;24:451–4.CrossRefPubMedGoogle Scholar
- 46.Riberti C, Marola G, Bertani A. Malignant melanoma: the adverse effect of pregnancy. Br J Plast Surg. 1981;34(3):338–9.CrossRefPubMedGoogle Scholar
- 47.Pack GT, Scharnagel IM. The prognosis for malignant melanoma in the pregnant woman. Cancer. 1951;4(2):324–34.CrossRefPubMedGoogle Scholar
- 48.Slingluff CL Jr, Reintgen DS, Vollmer RT, Seigler HF. Malignant melanoma arising during pregnancy. A study of 100 patients. Ann Surg. 1990;211(5):552–7. discussion 8-9CrossRefPubMedPubMedCentralGoogle Scholar
- 49.Kyrgidis A, Lallas A, Moscarella E, Longo C, Alfano R, Argenziano G. Does pregnancy influence melanoma prognosis? A meta-analysis. Melanoma Res. 2017;27(4):289–99.CrossRefPubMedGoogle Scholar
- 50.Mendizabal E, De Leon-Luis J, Gomez-Hidalgo NR, Joigneau L, Pintado P, Rincon P, et al. Maternal and perinatal outcomes in pregnancy-associated melanoma. Report of two cases and a systematic literature review. Eur J Obstet Gynecol Reprod Biol. 2017;214:131–9.CrossRefPubMedGoogle Scholar
- 51.Byrom L, Olsen C, Knight L, Khosrotehrani K, Green AC. Increased mortality for pregnancy-associated melanoma: systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2015;29(8):1457–66.CrossRefPubMedGoogle Scholar
- 52.Martires KJ, Stein JA, Grant-Kels JM, Driscoll MS. Meta-analysis concerning mortality for pregnancy-associated melanoma. J Eur Acad Dermatol Venereol. 2016;30(10):e107-e8.CrossRefGoogle Scholar
- 53.Khosrotehrani K, Olsen CM, Byrom L, Green AC. Melanoma during pregnancy: level of evidence and principles of precaution. J Am Acad Dermatol. 2017;76(1):e29–e30.CrossRefPubMedGoogle Scholar
- 54.Kyrgidis A, Argenziano G, Moscarella E, Longo C, Alfano R, Lallas A. Increased mortality for pregnancy-associated melanoma: different outcomes pooled together, selection and publication biases. J Eur Acad Dermatol Venereol. 2016;30(9):1618.CrossRefPubMedGoogle Scholar
- 55.Lens MB, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B, et al. Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol. 2004;22(21):4369–75.CrossRefPubMedGoogle Scholar
- 56.O'Meara AT, Cress R, Xing G, Danielsen B, Smith LH. Malignant melanoma in pregnancy. A population-based evaluation. Cancer. 2005;103(6):1217–26.CrossRefPubMedGoogle Scholar
- 57.Johansson AL, Andersson TM, Plym A, Ullenhag GJ, Moller H, Lambe M. Mortality in women with pregnancy-associated malignant melanoma. J Am Acad Dermatol. 2014;71(6):1093–101.CrossRefPubMedGoogle Scholar
- 58.Moller H, Purushotham A, Linklater KM, Garmo H, Holmberg L, Lambe M, et al. Recent childbirth is an adverse prognostic factor in breast cancer and melanoma, but not in Hodgkin lymphoma. Eur J Cancer. 2013;49(17):3686–93.CrossRefPubMedGoogle Scholar
- 59.Silipo V, De Simone P, Mariani G, Buccini P, Ferrari A, Catricala C. Malignant melanoma and pregnancy. Melanoma Res. 2006;16(6):497–500.CrossRefPubMedGoogle Scholar
- 60.Daryanani D, Plukker JT, De Hullu JA, Kuiper H, Nap RE, Hoekstra HJ. Pregnancy and early-stage melanoma. Cancer. 2003;97(9):2248–53.CrossRefPubMedGoogle Scholar
- 61.Travers RL, Sober AJ, Berwick M, Mihm MC Jr, Barnhill RL, Duncan LM. Increased thickness of pregnancy-associated melanoma. Br J Dermatol. 1995;132(6):876–83.CrossRefPubMedGoogle Scholar
- 62.Wong JH, Sterns EE, Kopald KH, Nizze JA, Morton DL. Prognostic significance of pregnancy in stage I melanoma. Arch Surg. 1989;124(10):1227–30; discussion 30–1CrossRefPubMedGoogle Scholar
- 63.Tellez A, Rueda S, Conic RZ, Powers K, Galdyn I, Mesinkovska NA, et al. Risk factors and outcomes of cutaneous melanoma in women less than 50 years of age. J Am Acad Dermatol. 2016;74(4):731–8.CrossRefPubMedGoogle Scholar
- 64.Trapeznikov NN, Khasanov Sh R, Iavorskii VV. Melanoma of the skin and pregnancy. Vopr Onkologii. 1987;33(6):40–6.Google Scholar
- 65.Driscoll MS, Martires K, Bieber AK, Pomeranz MK, Grant-Kels JM, Stein JA. Pregnancy and melanoma. J Am Acad Dermatol. 2016;75(4):669–78.CrossRefPubMedGoogle Scholar
- 66.Martires KJ, Pomeranz MK, Stein JA, Grant-Kels JM, Driscoll MS. Pregnancy-associated melanoma (PAMM): is there truly a worse prognosis? Would not sound alarm bells just yet. J Am Acad Dermatol. 2016;75(2):e77.CrossRefPubMedGoogle Scholar
- 67.Pages C, Robert C, Thomas L, Maubec E, Sassolas B, Granel-Brocard F, et al. Management and outcome of metastatic melanoma during pregnancy. Br J Dermatol. 2010;162(2):274–81.CrossRefPubMedGoogle Scholar
- 68.de Haan J, Lok CA, de Groot CJ, Crijns MB, Van Calsteren K, Dahl Steffensen K, et al. Melanoma during pregnancy: a report of 60 pregnancies complicated by melanoma. Melanoma Res. 2017;27(3):218–23.CrossRefPubMedGoogle Scholar
- 69.Miller E, Barnea Y, Gur E, Leshem D, Karin E, Weiss J, et al. Malignant melanoma and pregnancy: Second thoughts. J Plast Reconstr Aesthet Surg. 2010;63(7):1163–8.CrossRefPubMedGoogle Scholar
- 70.Reintgen DS, McCarty KS Jr, Vollmer R, Cox E, Seigler HF. Malignant melanoma and pregnancy. Cancer. 1985;55(6):1340–4.CrossRefPubMedGoogle Scholar
- 71.Bleau N, Patenaude V, Abenhaim HA. Risk of venous thrombo-embolic events in pregnant patients with cancer. J Matern Fetal Neonatal Med. 2016;29(3):380–4.PubMedGoogle Scholar
- 72.Lee YY, Roberts CL, Young J, Dobbins T. Using hospital discharge data to identify incident pregnancy-associated cancers: a validation study. BMC Pregnancy Childbirth. 2013;13:37.CrossRefPubMedPubMedCentralGoogle Scholar
- 73.Langagergaard V. Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin’s disease: a review. Clin Epidemiol. 2010;3:7–19.CrossRefPubMedPubMedCentralGoogle Scholar
- 74.Langagergaard V, Puho EH, Lash TL, Norgard B, Sorensen HT. Birth outcome in Danish women with cutaneous malignant melanoma. Melanoma Res. 2007;17(1):31–6.CrossRefPubMedGoogle Scholar
- 75.Dildy GA III, Moise KJ, Carpenter RJ Jr, et al. Maternal malignancy metastatic to the products of conception: a review. Obstet Gynecol Surv. 1989;44:5.CrossRefGoogle Scholar
- 76.Eltorky MKV, Osborne P, et al. Placental metastasis from maternal carcinoma: a report of three cases. J Reprod Med. 1995;40:4.Google Scholar
- 77.Alexander A, Samlowski WE, Grossman D, Bruggers CS, Harris RM, Zone JJ, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol. 2003;21(11):2179–86.CrossRefPubMedGoogle Scholar
- 78.Patenaude Y, Pugash D, Lim K, Morin L, Diagnostic Imaging C, Lim K, et al. The use of magnetic resonance imaging in the obstetric patient. J Obstet Gynaecol Can. 2014;36(4):349–63.CrossRefPubMedGoogle Scholar
- 79.Andtbacka RH, Donaldson MR, Bowles TL, Bowen GM, Grossmann K, Khong H, et al. Sentinel lymph node biopsy for melanoma in pregnant women. Ann Surg Oncol. 2013;20(2):689–96.CrossRefPubMedGoogle Scholar
- 80.Hu Y, Melmer PD, Slingluff CL Jr. Localization of the sentinel lymph node in melanoma without blue dye. Ann Surg. 2016;263(3):588–92.CrossRefPubMedPubMedCentralGoogle Scholar
- 81.Broer N, Buonocore S, Goldberg C, Truini C, Faries MB, Narayan D, et al. A proposal for the timing of management of patients with melanoma presenting during pregnancy. J Surg Oncol. 2012;106(1):36–40.CrossRefPubMedPubMedCentralGoogle Scholar
- 82.Leachman SA, Jackson R, Eliason MJ, Larson AA, Bolognia JL. Management of melanoma during pregnancy. Dermatol Nurs. 2007;19(2):145–52. 61PubMedGoogle Scholar
- 83.Beyeler M, Hafner J, Beinder E, Fauchere JC, Stoeckli SJ, Fehr M, et al. Special considerations for stage IV melanoma during pregnancy. Arch Dermatol. 2005;141(9):1077–9.CrossRefPubMedGoogle Scholar
- 84.Maleka A, Enblad G, Sjors G, Lindqvist A, Ullenhag GJ. Treatment of metastatic malignant melanoma with vemurafenib during pregnancy. J Clin Oncol. 2013;31(11):e192–3.CrossRefPubMedGoogle Scholar
- 85.Grunewald S, Jank A. New systemic agents in dermatology with respect to fertility, pregnancy, and lactation. J Dtsch Dermatol Ges. 2015;13:277.PubMedGoogle Scholar
- 86.Wang SCLY, Piao HL, Hong XW, Zhang D, Xu YY, et al. PD-1 and Tim-3 pathways are associated with regulatory CD8+ T cell function in decidua and maintenance of normal pregnancy. Cell Death Dis. 2015;6:e1738.CrossRefPubMedPubMedCentralGoogle Scholar
- 87.Ribero S, Longo C, Dika E, Fortes C, Pasquali S, Nagore E, et al. Pregnancy and melanoma: A European-wide survey to assess current management and a critical literature overview. J Eur Acad Dermatol Venereol. 2017;31(1):65–9.CrossRefPubMedGoogle Scholar
- 88.Stensheim H, Cvancarova M, Moller B, Fossa SD. Pregnancy after adolescent and adult cancer: a population-based matched cohort study. Int J Cancer. 2011;129(5):1225–36.CrossRefPubMedGoogle Scholar
- 89.Byrom L, Olsen CM, Knight L, Khosrotehrani K, Green AC. Does pregnancy after a diagnosis of melanoma affect prognosis? Systematic review and meta-analysis. Dermatol Surg. 2015;41(8):875–82.CrossRefPubMedGoogle Scholar
- 90.Brady MS, Noce NS. Pregnancy is not detrimental to the melanoma patient with clinically localized disease. J Clin Aesthet Dermatol. 2010;3(3):22–8.PubMedPubMedCentralGoogle Scholar
- 91.Albersen M, Westerling VI, van Leeuwen PA. The influence of pregnancy on the recurrence of cutaneous malignant melanoma in women. Dermatol Res Pract. 2010;2010Google Scholar
- 92.MacKie RM, Bufalino R, Morabito A, Sutherland C, Cascinelli N. Lack of effect of pregnancy on outcome of melanoma. For the World Health Organisation Melanoma Programme. Lancet. 1991;337(8742):653–5.CrossRefPubMedGoogle Scholar
- 93.Karagas MR, Zens MS, Stukel TA, Swerdlow AJ, Rosso S, Osterlind A, et al. Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control. 2006;17(1):11–9.CrossRefPubMedGoogle Scholar
- 94.Naldi LAA, Imberti GL, Giordano L, Gallus S, La Vecchia C. Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED). Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann Epidemiol. 2005;15:5.CrossRefGoogle Scholar
- 95.Lea CSHE, Hartge P, et al. Reproductive risk factors for cutaneous melanoma in women: a case-control study. Am J Epidemiol. 2007;165:8.Google Scholar
- 96.Mackie RM, Bray CA. Hormone replacement therapy after surgery for stage I or II cutaneous melanoma. Br J Cancer. 2004;90:2.CrossRefGoogle Scholar